Saturday - April 19, 2025
UT-MD Anderson Cancer Center: NK Cells Complexed With Bispecific Antibody Yield High Response Rates in Patients With Lymphoma
April 05, 2025
HOUSTON, Texas, April 5 -- The University of Texas MD Anderson Cancer Center issued the following news release:

* * *

NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma

Phase I trial demonstrates AFM13-NK cells are safe and highly effective in heavily pretreated patients

HOUSTON - A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products